Cargando…
A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors
The global scourge of COVID-19 is a serious threat to public health, but effective therapies remain very limited for this disease. Therefore, the discovery of novel antiviral agents is urgently needed to fight against COVID-19. In the lifecycle of SARS-CoV-2, the causing pathogen of COVID-19, papain...
Autores principales: | Yan, Haohao, Liu, Zhicheng, Yan, Gangan, Liu, Xiaoli, Liu, Xiaoping, Wang, Yanchang, Chen, Yunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287753/ https://www.ncbi.nlm.nih.gov/pubmed/35870326 http://dx.doi.org/10.1016/j.virol.2022.07.006 |
Ejemplares similares
-
Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay
por: Zhang, Jing, et al.
Publicado: (2022) -
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors
por: Yan, Gangan, et al.
Publicado: (2021) -
Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease
por: Yan, Haohao, et al.
Publicado: (2023) -
Protocol for in vitro fluorescence assay of papain-like protease and cell-based immunofluorescence assay of coronavirus infection
por: Chang, JuOae, et al.
Publicado: (2023) -
Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease
por: Li, Dongsheng, et al.
Publicado: (2022)